Cwm, LLC Vericel Corp Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Vericel Corp stock. As of the latest transaction made, Cwm, LLC holds 1,103 shares of VCEL stock, worth $62,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,103

Previous 662 66.62%

Holding current value

$62,529

Previous $30,000 56.67%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$42.25 - $53.56 $18,632 - $23,619	441 Added 66.62%	1,103 $47,000
Q2 2024 Jul 09, 2024	BUY	$41.71 - $52.9 $21,021 - $26,661	504 Added 318.99%	662 $30,000
Q1 2024 Apr 05, 2024	SELL	$32.52 - $52.33 $2,536 - $4,081	-78 Reduced 33.05%	158 $8,000
Q4 2023 Feb 01, 2024	SELL	$30.85 - $37.09 $1,357 - $1,631	-44 Reduced 15.71%	236 $8,000
Q2 2023 Aug 03, 2023	SELL	$29.0 - $38.37 $2,842 - $3,760	-98 Reduced 25.93%	280 $11,000
Q1 2023 Apr 28, 2023	BUY	$23.85 - $31.34 $190 - $250	8 Added 2.16%	378 $11,000
Q4 2022 Feb 01, 2023	SELL	$17.65 - $27.37 $1,641 - $2,545	-93 Reduced 20.09%	370 $10,000
Q3 2022 Oct 27, 2022	BUY	$22.62 - $32.54 $8,007 - $11,519	354 Added 324.77%	463 $11,000
Q2 2022 Jul 28, 2022	SELL	$22.88 - $39.45 $6,680 - $11,519	-292 Reduced 72.82%	109 $3,000
Q1 2022 Apr 21, 2022	BUY	$31.69 - $43.29 $5,735 - $7,835	181 Added 82.27%	401 $15,000
Q4 2021 Jan 31, 2022	BUY	$35.2 - $52.6 $7,110 - $10,625	202 Added 1122.22%	220 $9,000
Q1 2019 Apr 22, 2019	BUY	$16.23 - $20.29 $292 - $365	18 New	18 $0

Others Institutions Holding VCEL

# of Institutions

277

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account